Chronic kidney disease affects 13.4% of the world population. This disease is especially common in elderly people (> 65 years); which has led to an increase in mortality by one third over the last decade. At the final stage of the disease, 38% of deaths are sudden deaths due to cardiac arrhythmias – ventricular tachycardia and bradycardia. Patients undergoing end-stage disease are treated with hemodialysis 3 times a week with increased time intervals between treatments at the weekends. About 50% of life-threatening episodes of arrhythmias occur on the last day of the long interval, which is associated with an increase in fluid in the body and electrolyte imbalance. The KidneyLife project aims to create and explore non-invasive, unobtrusive technology for detection of life-threatening conditions by using multimodal biosignals: bio-optic, bio-electric, and biomechanical. The comfort of the wearer will be ensured by integrating biosignal sensors and developed algorithms into a wrist-worn device.
Project funding:
This research project is funded by the European Regional Development Fund according to the 2014–2020 Operational Programme for the European Union Funds’ Investments, under measure’s No. 01.2.2-LMT-K-718 activity “Research Projects Implemented by World-class Researcher Groups”
Project results:
It is planned to submit patent applications to the Lithuanian and European patent offices, the results will be described in six scientific articles with an impact factor.
Period of project implementation: 2018-01-02 - 2022-06-30
Project coordinator: Kaunas University of Technology
